Rekvina Laboratories Schedules EGM for April 10 to Approve Capital Restructuring
Published on: March 18, 2026, 2:24 p.m. | Source: scanx.trade
Rekvina Laboratories has formally notified shareholders of an extraordinary general meeting on April 10, 2026, to vote on increasing authorized share capital from ₹3.50 crore to ₹6 crore, acquiring 100% stake in Radiant Parenterals for ₹4.62 crore through share exchange, and issuing additional equity shares for cash consideration.
